We are live on
!
Find out more
MAP
Moody Aldrich Partners Portfolio holdings
AUM
$557M
1-Year Est. Return
122.79%
This Fund
S&P 500
This Quarter
Est. Return
+12.54%
1 Year Est. Return
+122.79%
3 Year Est. Return
+335.86%
5 Year Est. Return
+437.05%
10 Year Est. Return
+2,951.39%
AUM
$281M
AUM Growth
+$125M
(+80%)
Cap. Flow
+$112M
Cap. Flow
% of AUM
39.68%
Top 10 Holdings %
Top 10 Hldgs %
20.88%
Holding
121
New
35
Increased
49
Reduced
11
Closed
26
Avg Time Held
3.2
quarters
Top 10 Avg Time Held
1.2
quarters
Top 20 Avg Time Held
2.1
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Calavo Growers
CVGW
|
+$5.11M |
| 2 |
Amedisys
AMED
|
+$4.94M |
| 3 |
Ligand Pharmaceuticals
LGND
|
+$4.73M |
| 4 |
WBT
Welbilt, Inc.
WBT
|
+$4.2M |
| 5 |
STMP
Stamps.com, Inc.
STMP
|
+$3.93M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wintrust Financial
WTFC
|
+$4.23M |
| 2 |
ZEN
ZENDESK INC
ZEN
|
+$3.71M |
| 3 |
Central Garden & Pet Co
CENT
|
+$2.68M |
| 4 |
Monolithic Power Systems
MPWR
|
+$2.51M |
| 5 |
Pegasystems
PEGA
|
+$2.48M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.03% |
| 2 | Technology | 17.51% |
| 3 | Financials | 17.01% |
| 4 | Industrials | 11.58% |
| 5 | Consumer Discretionary | 10.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Silicon Laboratories
SLAB
$7.41B
| $6.76M | 2.4% |
67,851
+23,503
| +53% | +$2.35M |
2016 Q1
9 quarters
|
|
2
Terreno Realty
TRNO
$7.06B
| $6.36M | 2.26% |
168,870
+70,598
| +72% | +$2.6M |
2016 Q3
7 quarters
|
|
|
CSFL
3
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $6.28M | 2.23% |
210,416
+102,227
| +94% | +$3.04M |
2017 Q4
2 quarters
|
|
4
Steven Madden
SHOO
$3.24B
| $5.82M | 2.07% |
164,288
+96,857
| +144% | +$3.25M |
2016 Q4
6 quarters
|
|
|
5
DELISTED
Amedisys
AMED
| $5.75M | 2.04% |
+67,299
| New | +$4.94M |
2018 Q2
0 quarters
|
|
6
Eagle Bancorp
EGBN
$860M
| $5.65M | 2.01% |
92,115
+39,503
| +75% | +$2.4M |
2016 Q4
6 quarters
|
|
7
Triumph Financial Inc
TFIN
$1.49B
| $5.57M | 1.98% |
136,690
+72,913
| +114% | +$2.95M |
2018 Q1
1 quarter
|
|
8
AMN Healthcare
AMN
$1.41B
| $5.56M | 1.98% |
94,922
+55,218
| +139% | +$3.3M |
2018 Q1
1 quarter
|
|
9
Rexford Industrial Realty
REXR
$8.19B
| $5.52M | 1.96% |
175,895
+75,266
| +75% | +$2.3M |
2017 Q2
4 quarters
|
|
|
10
Ligand Pharmaceuticals
LGND
$6.02B
| $5.48M | 1.95% |
+42,370
| New | +$4.73M |
2018 Q2
0 quarters
|
|
|
11
DELISTED
Calavo Growers
CVGW
| $5.28M | 1.88% |
+54,939
| New | +$5.11M |
2018 Q2
0 quarters
|
|
12
Independent Bank
INDB
$3.65B
| $5.26M | 1.87% |
67,090
+28,680
| +75% | +$2.19M |
2016 Q1
9 quarters
|
|
13
Columbia Banking Systems
COLB
$8.03B
| $5.11M | 1.82% |
124,941
+53,460
| +75% | +$2.28M |
2017 Q4
2 quarters
|
|
14
DELISTED
Brookline Bancorp
BRKL
| $4.92M | 1.75% |
264,308
+80,971
| +44% | +$1.42M |
2016 Q1
9 quarters
|
|
|
WBT
15
DELISTED
Welbilt, Inc.
WBT
| $4.69M | 1.67% |
+210,224
| New | +$4.2M |
2018 Q2
0 quarters
|
|
16
Fair Isaac
FICO
$14.4B
| $4.62M | 1.64% |
23,912
+9,818
| +70% | +$1.78M |
2016 Q1
9 quarters
|
|
|
AERI
17
DELISTED
Aerie Pharmaceuticals
AERI
| $4.37M | 1.55% |
64,655
+23,498
| +57% | +$1.31M |
2017 Q3
3 quarters
|
|
|
KMG
18
DELISTED
KMG Chemicals Inc
KMG
| $4.35M | 1.55% |
58,978
+25,255
| +75% | +$1.7M |
2018 Q1
1 quarter
|
|
|
LOXO
19
DELISTED
Loxo Oncology, Inc
LOXO
| $4.31M | 1.53% |
24,858
+10,667
| +75% | +$1.6M |
2018 Q1
1 quarter
|
|
20
Standex International
SXI
$3.5B
| $4.22M | 1.5% |
41,274
+17,660
| +75% | +$1.76M |
2016 Q1
9 quarters
|
|
|
STMP
21
DELISTED
Stamps.com, Inc.
STMP
| $4.13M | 1.47% |
+16,330
| New | +$3.93M |
2018 Q2
0 quarters
|
|
22
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $4.13M | 1.47% |
+86,988
| New | +$3.7M |
2018 Q2
0 quarters
|
|
23
Entegris
ENTG
$25.3B
| $4.08M | 1.45% |
120,437
+27,828
| +30% | +$985K |
2016 Q1
9 quarters
|
|
24
Chord Energy
CHRD
$7.74B
| $4.05M | 1.44% |
312,611
+177,181
| +131% | +$2.02M |
2016 Q3
7 quarters
|
|
25
Globus Medical
GMED
$10B
| $4.04M | 1.44% |
80,120
+41,112
| +105% | +$2.14M |
2018 Q1
1 quarter
|
|
Similar funds
FG
NB
WCMN
STAS
BWM
MP
WDG
FAM
Moody Aldrich Partners's Q2 2018 Portfolio in Review
As of Q2 2018, Moody Aldrich Partners held 121 positions worth $281M, up 80% from $156M the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Moody Aldrich Partners deployed $112M of net new capital in Q2 2018, opening 35 new positions and adding to 49 existing holdings. Its largest new stake was Calavo Growers: 54,939 shares worth $5.28M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 11% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Unifirst Corp, an estimated $663K trimmed.
- Moody Aldrich Partners's largest Q2 2018 buy was Calavo Growers: 54,939 shares worth $5.28M.
- Moody Aldrich Partners added most to AMN Healthcare in Q2 2018, an estimated $3.3M increase.
- Moody Aldrich Partners's biggest Q2 2018 reduction was Unifirst Corp, cutting an estimated $663K.
- Moody Aldrich Partners fully exited Wintrust Financial in Q2 2018, selling an estimated $4.23M.
- Moody Aldrich Partners's ten largest holdings make up 21% of its $281M portfolio in Q2 2018.
- Moody Aldrich Partners opened 35 new positions and closed 26 in Q2 2018.
- Moody Aldrich Partners's portfolio value rose 80% quarter-over-quarter to $281M.
Based on Moody Aldrich Partners's 13F filing for Q2 2018, filed 13 Aug 2018.